Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

ClinicalTrials.gov ID: NCT00709371

Public ClinicalTrials.gov record NCT00709371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIB, Multi-Center, Dose-Parallel, Randomized, Double-Blind, Monotherapy and Placebo-Controlled Safety and Efficacy Study of Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is determine if the combination of zonisamide SR and bupropion SR are is more effective than either drug given alone or placebo in the treatment of obesity.

Study identification

NCT ID
NCT00709371
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Orexigen Therapeutics, Inc
Industry
Enrollment
729 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Mar 31, 2009
Completion
Jun 30, 2009
Last update posted
Nov 28, 2012

2008 – 2009

United States locations

U.S. sites
20
U.S. states
18
U.S. cities
20
Facility City State ZIP Site status
SelfCenter, PC Fairhope Alabama 36532
Nutrition and Metabolic Research La Jolla California 92037
Center for Human Nutrition/UCD Denver Colorado 80220
Miami Research Associates Miami Florida 33143
CSRA Partners in Health, Inc. Augusta Georgia 30909
Radiant Research, Chicago Chicago Illinois 60610
Welborn Clinic Evansville Indiana 47713
Pennington Biomedical Research Center Baton Rouge Louisiana 70808
Nutrition and Weight Management Center, Boston Medical Center Boston Massachusetts 02118
FutureCare Studies Springfield Massachusetts 01103
Summit Research Network (Michigan), Inc. Farmington Hills Michigan 48336
Mercy Health Research St Louis Missouri 63141
Center for Nutrition and Metabolic Disorders, University of Nevada School of Medicine Reno Nevada 89557
Behavioral Medical Research Staten Island New York 10305
Internal Medicine Associates of Charlotte Charlotte North Carolina 28277
Wake Research Associates, LLC Raleigh North Carolina 27612
Summit Research Network (Oregon), Inc. Portland Oregon 97210
The Cooper Institute Dallas Texas 75230
Washington Center for Weight Management and Research Arlington Virginia 22201
Summit Research Network (Seattle), LLC. Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00709371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00709371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →